3C-BZ
 |
|
 |
|
| Names | |
|---|---|
| IUPAC name
4-Benzyloxy-3,5-methoxy-alpha-methyl-1-ethane
|
|
| Other names
4-Benzyloxy-3,5-methoxy-amphetamine
|
|
| Identifiers | |
147947-26-0  |
|
| ChEMBL | ChEMBL127871  |
| ChemSpider | 21106236 |
| Jmol 3D model | Interactive image |
|
|
|
|
| Properties | |
| C18H23NO3 | |
| Molar mass | 301.39 g/mol |
| Vapor pressure | {{{value}}} |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
 verify (what is ?) |
|
| Infobox references | |
3C-BZ, or 3,5-dimethoxy-4-benzyloxyamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. 3C-BZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 25–200 mg, and the duration as 18–24 hours. According to anecdotal reports from the substance's entry in PiHKAL, 3C-BZ's effects can vary significantly, ranging from intensified emotions and strange dreams, to effects similar to those of LSD or TMA.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 3C-BZ.
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
